Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Interactions of Nucleoside Analogs, Caffeine, and Nicotine with Human Concentrative Nucleoside Transporters 1 and 2 Stably Produced in a Transport-Defective Human Cell Line

Thack T. Lang, James D. Young and Carol E. Cass
Molecular Pharmacology April 2004, 65 (4) 925-933; DOI: https://doi.org/10.1124/mol.65.4.925
Thack T. Lang
From the Canadian Institutes of Health Research Molecular Biology of Membranes Group (T.T.L., J.D.Y., C.E.C.), Departments of Oncology (T.T.L., C.E.C.) and Physiology (J.D.Y.), University of Alberta, Edmonton, Alberta, Canada; and the Cross Cancer Institute, Edmonton, Alberta, Canada (T.T.L., C.E.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Young
From the Canadian Institutes of Health Research Molecular Biology of Membranes Group (T.T.L., J.D.Y., C.E.C.), Departments of Oncology (T.T.L., C.E.C.) and Physiology (J.D.Y.), University of Alberta, Edmonton, Alberta, Canada; and the Cross Cancer Institute, Edmonton, Alberta, Canada (T.T.L., C.E.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol E. Cass
From the Canadian Institutes of Health Research Molecular Biology of Membranes Group (T.T.L., J.D.Y., C.E.C.), Departments of Oncology (T.T.L., C.E.C.) and Physiology (J.D.Y.), University of Alberta, Edmonton, Alberta, Canada; and the Cross Cancer Institute, Edmonton, Alberta, Canada (T.T.L., C.E.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Pharmacologically important drugs were examined as potential inhibitors or permeants of human concentrative nucleoside transporters 1 (hCNT1)- and 2 (hCNT2)-producing stable transfectants by assessing their abilities to inhibit uridine transport. hCNT1 exhibited high affinities for uridine analogs (5-fluorouridine, 2′-deoxyuridine, 5-fluoro-2′-deoxyuridine, and 5-fluoro-5′-deoxyuridine) with Ki values of 22 to 33 μM, whereas hCNT2 exhibited moderate affinities for 5-fluoro-2′-deoxyuridine, high affinities for 2′-deoxyuridine and 5-fluorouridine, and low affinity for 5-fluoro-5′-deoxyuridine. The uridine analogs were transported at 2-fold higher rates (at 10 μM) by hCNT1 than by hCNT2. Enantiomeric configuration and the 3′-hydroxyl group of the ribose ring were important determinants for interaction with hCNTs, whereas the 2′-hydroxyl group was less important. Both transporters bound N6-(p-aminobenzyl)adenosine with affinities similar to those of adenosine (Ki = 28-39 μM). Other adenosine receptor ligands, including caffeine, bound better to hCNT1 than to hCNT2 (Ki = 46 versus 103 μM, respectively), whereas 2-chloroadenosine bound better to hCNT2 than to hCNT1 (Ki = 37 and 101 μM, respectively). There was a greater than 3-fold difference in binding affinities between hCNT1 and hCNT2 for nicotine (Ki = 63 versus 227 μM). However, direct measurements of nicotine and caffeine uptake rates (10 μM) failed to demonstrate mediated uptake by either transporter. Although hCNT1 bound several adenosine analogs relatively well, it did not transport 2-chloro-2′-deoxyadenosine (cladribine) or 2-fluoro-9-β-d-arabinofuranosyladenine (fludarabine), whereas hCNT2 transported both, albeit with low activities. The results indicated that although hCNT1 and hCNT2 possess some overlap in transport of several uridine and adenosine analogs, they also exhibit distinct differences in capacity to interact with some adenosine receptor ligands, adenosine-based drugs, and nicotine.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 65 (4)
Molecular Pharmacology
Vol. 65, Issue 4
1 Apr 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interactions of Nucleoside Analogs, Caffeine, and Nicotine with Human Concentrative Nucleoside Transporters 1 and 2 Stably Produced in a Transport-Defective Human Cell Line
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interactions of Nucleoside Analogs, Caffeine, and Nicotine with Human Concentrative Nucleoside Transporters 1 and 2 Stably Produced in a Transport-Defective Human Cell Line

Thack T. Lang, James D. Young and Carol E. Cass
Molecular Pharmacology April 1, 2004, 65 (4) 925-933; DOI: https://doi.org/10.1124/mol.65.4.925

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Interactions of Nucleoside Analogs, Caffeine, and Nicotine with Human Concentrative Nucleoside Transporters 1 and 2 Stably Produced in a Transport-Defective Human Cell Line

Thack T. Lang, James D. Young and Carol E. Cass
Molecular Pharmacology April 1, 2004, 65 (4) 925-933; DOI: https://doi.org/10.1124/mol.65.4.925
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics